The Royal Swedish Academy of Sciences announced on Wednesday that Henri B. Kagan and Kenso Soai have been awarded the 2026 Nobel Prize in Chemistry, recognizing their pioneering work on non-linear effects and autocatalysis in asymmetric organic synthesis. The announcement, made in Stockholm, caps decades of research into one of chemistry's most enduring puzzles.
Heiner Linke, who chairs the Nobel Committee for Chemistry, explained the significance of the pair's achievements in a statement accompanying the award. According to Linke, the two laureates have resolved a question that has confounded scientists for more than a hundred years: how homochirality — the phenomenon in which biological molecules consistently favor one of two mirror-image forms — can arise on its own. He described the chemical reactions the two men developed as "spectacular."
The committee's news release emphasized that the discoveries "have been decisive for chemists who design reactions for the manufacture of pharmaceuticals." That endorsement points to the practical weight of the work, which sits at the intersection of fundamental theory and industrial application.
Kagan, who was born in France, is affiliated with Université Paris-Sud in Orsay. Soai, who was born in Japan and is 95 years old, is associated with the Tokyo University of Science. The two researchers come from different generations and different national traditions, but their contributions converged on a shared problem: understanding how chemical reactions can amplify a tiny imbalance between mirror-image molecules into a decisive preference for one form over the other.
The concept of chirality is central to the award. Many molecules exist in two versions that are mirror images of each other, much like a left hand and a right hand. While they may look nearly identical, these mirror forms — known as enantiomers — can behave very differently in biological systems. That is why pharmaceutical chemists care deeply about producing drugs with the correct handedness, since the wrong form can be ineffective or even harmful.
In living organisms, this handedness is remarkably consistent. Proteins are built almost exclusively from left-handed amino acids, while the sugars in DNA and RNA are right-handed. This uniform preference, called homochirality, is one of the defining features of life on Earth. Yet explaining how it first emerged from a prebiotic soup of simple chemicals, where both forms should have been equally likely, has long been a source of scientific debate.
The work honored by the Nobel committee offers a chemical mechanism for this emergence. Non-linear effects, one of the areas Kagan studied, describe how small differences in the starting mixture of a reaction can be amplified in unexpected, disproportionate ways rather than remaining proportional. Autocatalysis, the second key concept, describes reactions in which the products of a chemical process accelerate their own formation — a kind of self-reinforcing feedback loop.
The so-called "Soai reaction" is named after Kenso Soai's landmark experiment, which demonstrated that such self-amplifying chemistry can indeed generate a strong preference for one mirror form from a nearly balanced starting point. The reaction has become a textbook example of how chirality can be amplified without any external biological guidance, offering a plausible route by which nature's one-handed biochemistry might have gotten its start.
The implications for medicine and industry are substantial. Because the handedness of a drug molecule can determine whether it works as intended, chemists designing pharmaceutical manufacturing processes need reliable ways to produce a single desired enantiomer. The insights from Kagan and Soai's research give chemists tools and theoretical grounding for controlling that outcome, which the Nobel committee said has proven decisive for drug development.
The chemistry prize is one of the traditional scientific Nobel categories and typically follows the medicine award in the annual announcement schedule. This year's prizes opened on Monday with the medicine Nobel, which went to three scientists whose work led to a tool that uses a related molecular approach. Last year's chemistry prize honored three researchers who developed new molecular structures capable of trapping large quantities of gas inside them, an advance with potential applications ranging from removing greenhouse gases from the atmosphere to harvesting moisture in desert environments.
This year's chemistry award returns the spotlight to a more fundamental question about the origins of biological order. Where last year's laureates looked outward — toward environmental and climate applications — Kagan and Soai's recognition highlights an inward-looking inquiry: how the molecular building blocks of life came to prefer one hand over the other.
The Nobel Prize in Chemistry is awarded annually by the Royal Swedish Academy of Sciences, with the committee evaluating nominations and selecting laureates whose work is judged to have conferred the greatest benefit to humankind. The award carries substantial prestige and a significant monetary prize, and it often reshapes how both scientists and the public understand a particular field.
For Kagan and Soai, the honor arrives after long careers devoted to organic synthesis and stereochemistry. Their combined body of work has bridged theoretical chemistry and practical drug-making, and the committee's citation frames their achievements as a resolution to a mystery that is, in Linke's words, over a century old. In honoring the discovery of non-linear effects and autocatalysis, the academy has recognized research that explains not only how chemists can control molecular handedness, but also how nature itself may have done so at the dawn of life.
(0)